These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 2018629)
1. Prolactin responses to haloperidol in drug-free and treated schizophrenic patients. Markianos M; Sakellariou G; Bistolaki E J Neural Transm Gen Sect; 1991; 83(1-2):37-42. PubMed ID: 2018629 [TBL] [Abstract][Full Text] [Related]
2. Neuroendocrine serotonergic and dopaminergic responsivity in male schizophrenic patients during treatment with neuroleptics and after switch to risperidone. Markianos M; Hatzimanolis J; Lykouras L Psychopharmacology (Berl); 2001 Aug; 157(1):55-9. PubMed ID: 11512043 [TBL] [Abstract][Full Text] [Related]
3. Prolactin and TSH responses to TRH and to haloperidol in schizophrenic patients before and after treatment. Markianos M; Hatzimanolis J; Stefanis C Eur Neuropsychopharmacol; 1994 Dec; 4(4):513-6. PubMed ID: 7894262 [TBL] [Abstract][Full Text] [Related]
4. Dopamine receptor responsivity in schizophrenic patients before and after switch from haloperidol to risperidone. Markianos M; Hatzimanolis J; Lykouras L Psychiatry Res; 1999 Dec; 89(2):115-22. PubMed ID: 10646830 [TBL] [Abstract][Full Text] [Related]
5. Prolactin responses to acute clomipramine and haloperidol of male schizophrenic patients in a drug-free state and after treatment with clozapine or with olanzapine. Markianos M; Hatzimanolis J; Lykouras L; Christodoulou GN Schizophr Res; 2002 Jul; 56(1-2):11-7. PubMed ID: 12084414 [TBL] [Abstract][Full Text] [Related]
6. Plasma prolactin and homovanillic acid as markers for psychopathology and abnormal movements during maintenance haloperidol treatment in male patients with schizophrenia. Newcomer JW; Riney SJ; Vinogradov S; Csernansky JG Psychiatry Res; 1992 Mar; 41(3):191-202. PubMed ID: 1594706 [TBL] [Abstract][Full Text] [Related]
7. The relationship of dopamine receptor blockade to clinical response in schizophrenic patients treated with pimozide or haloperidol. Silverstone T; Cookson J; Ball R; Chin CN; Jacobs D; Lader S; Gould S J Psychiatr Res; 1984; 18(3):255-68. PubMed ID: 6387105 [TBL] [Abstract][Full Text] [Related]
8. Neuroendocrine tests during treatment with neuroleptic drugs I. Plasma prolactin response to haloperidol challenge. Kolakowska T; Braddock L; Wiles D; Franklin M; Gelder M Br J Psychiatry; 1981 Nov; 139():400-4. PubMed ID: 6120731 [TBL] [Abstract][Full Text] [Related]
9. Basal and haloperidol-stimulated prolactin in neuroleptic-free men with schizophrenia defined by 11 diagnostic systems. Keks NA; Copolov DL; Kulkarni J; Mackie B; Singh BS; McGorry P; Rubin RT; Hassett A; McLaughlin M; van Riel R Biol Psychiatry; 1990 Jun; 27(11):1203-15. PubMed ID: 2354227 [TBL] [Abstract][Full Text] [Related]
10. Dopamine receptor responsivity in schizophrenic patients in a drug-free state and after treatment with olanzapine. Lykouras L; Markianos M; Hatzimanolis J; Oulis P Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):507-18. PubMed ID: 11370994 [TBL] [Abstract][Full Text] [Related]
11. Effects of olanzapine and haloperidol on serum prolactin levels in male schizophrenic patients. Esel E; Basturk M; Saffet Gonul A; Kula M; Tayfun Turan M; Yabanoglu I; Sofuoglu S Psychoneuroendocrinology; 2001 Aug; 26(6):641-7. PubMed ID: 11403983 [TBL] [Abstract][Full Text] [Related]
12. Antagonizing effect of lithium on the development of dopamine supersensitivity in the tuberoinfundibular system. Tanimoto K; Maeda K; Chihara K Brain Res; 1982 Aug; 245(1):163-6. PubMed ID: 6811103 [TBL] [Abstract][Full Text] [Related]
13. Prolactin responses to neuroleptics in normal and schizophrenic subjects. Gruen PH; Sachar EJ; Langer G; Altman N; Leifer M; Frantz A; Halpern FS Arch Gen Psychiatry; 1978 Jan; 35(1):108-16. PubMed ID: 23087 [TBL] [Abstract][Full Text] [Related]
14. Bromocriptine therapy in chronic schizophrenia: effects on symptomatology, sleep patterns, and prolactin response to stimulation. Brambilla F; Scarone S; Pugnetti L; Massironi R; Penati G; Nobile P Psychiatry Res; 1983 Mar; 8(3):159-69. PubMed ID: 6574535 [TBL] [Abstract][Full Text] [Related]
15. Prolactin levels in male schizophrenic patients treated with risperidone and haloperidol: a double-blind and randomized study. Zhang XY; Zhou DF; Cao LY; Zhang PY; Wu GY; Shen YC Psychopharmacology (Berl); 2005 Feb; 178(1):35-40. PubMed ID: 15289996 [TBL] [Abstract][Full Text] [Related]
16. Effect of clozapine on apomorphine-induced growth hormone secretion and serum prolactin concentrations in schizophrenia. Nair NP; Lal S; Cervantes P; Yassa R; Guyda H Neuropsychobiology; 1979; 5(3):136-42. PubMed ID: 431802 [TBL] [Abstract][Full Text] [Related]
17. Gonadal axis hormones in male schizophrenic patients during treatment with haloperidol and after switch to risperidone. Markianos M; Hatzimanolis J; Lykouras L Psychopharmacology (Berl); 1999 Apr; 143(3):270-2. PubMed ID: 10353429 [TBL] [Abstract][Full Text] [Related]
18. Serum prolactin response to chlorpromazine and psychopathology in schizophrenics: implications for the dopamine hypothesis. Meltzer HY; Busch D Psychiatry Res; 1983 Aug; 9(4):285-99. PubMed ID: 6580661 [TBL] [Abstract][Full Text] [Related]
19. Haloperidol. Plasma levels and prolactin response as predictors of clinical improvement in schizophrenia: chemical v radioreceptor plasma level assays. Smith RC; Baumgartner R; Misra CH; Mauldin M; Shvartsburd A; Ho BT; DeJohn C Arch Gen Psychiatry; 1984 Nov; 41(11):1044-9. PubMed ID: 6497566 [TBL] [Abstract][Full Text] [Related]
20. Change in plasma prolactin and clinical response to haloperidol in schizophrenia and schizoaffective disorder. Chou JC; Douyon R; Czobor P; Volavka J; Cooper TB Psychiatry Res; 1998 Oct; 81(1):51-5. PubMed ID: 9829650 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]